Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDirecta Plus Regulatory News (DCTA)

Share Price Information for Directa Plus (DCTA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.70
Bid: 18.40
Ask: 19.00
Change: 0.00 (0.00%)
Spread: 0.60 (3.261%)
Open: 18.70
High: 18.70
Low: 18.70
Prev. Close: 18.70
DCTA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition and Directa Textile Solutions launch

14 Nov 2016 07:00

RNS Number : 0365P
Directa Plus PLC
14 November 2016
 

14 November 2016

 

Directa Plus plc

("Directa Plus" or the "Company")

 

Acquisition of Osmotek and launch of Directa Textile Solutions

First implementation of the Company's downstream integration strategy

 

Directa Plus (AIM: DCTA), a producer and supplier of graphene-based products for use in consumer and industrial markets, is pleased to announce that its wholly-owned subsidiary, Directa Plus S.p.A., has acquired a 60% interest in the issued share capital of Osmotek Srl ("Osmotek"), a company involved in the commercialisation and distribution of textile membranes, for a total consideration of €60,000 to be invested in the business as working capital (the "Acquisition"). The Company has assumed responsibility for the operations of Osmotek, which has been renamed Directa Textile Solutions Srl ("DTS"). The Directors of the Company believe that the Acquisition will enhance the route-to-market for its textile applications.

 

Background to the Transaction

 

Osmotek, based in Milan, Italy, was founded in 2015, to focus on the commercialisation of textile membranes. Osmotek's focus in the textile membrane market is on sportswear, workwear, fashion and military applications. It has already built a base of clients and agents and has a good commercial pipeline.

 

Osmotek was founded by Novaresin, a large Italian membrane producer, and the existing shareholders of Osmotek will continue to hold a 40% shareholding in DTS post-Acquisition. Novaresin has a factory located in the North of Italy that is capable of producing 7 million metres of fabric per annum. It has a wide range of textile products and is a specialist in lamination whereby a textile membrane is laminated onto another fabric to enhance its properties, such as providing breathability or waterproofing. The Novaresin products include a new range of graphene-enhanced membranes for textile applications, which have been developed in conjunction with Directa Plus over the last year. The incorporation of the Company's graphene-based products enhances the textile membrane providing additional properties to the end fabric, such as electrical and thermal conductivity, bacteriostatic characteristics and abrasion resistance.

 

Rationale for the Transaction

 

The Acquisition and launch of DTS reflects the Company's strategy to utilise its know-how and IP to have a greater role in the graphene value chain. The main reasons for the Acquisition include:

 

· Directa Plus, through DTS, will directly promote and distribute its graphene-enhanced membrane products to textile brands and end clients.

· It will allow the Company to take advantage of the development to date of G+ membranes undertaken by Directa Plus and Novaresin, giving the Company greater control of the value and margin in the process from its development through to commercial sales.

· Directa Plus will be better positioned to communicate directly with the end client and pursue its branding strategy of featuring the 'G+' logo on the end product and packaging.

· DTS will leverage the integration of Directa Plus' technical capabilities regarding graphene, Novaresin's expertise in creating and producing technical membranes, and Osmotek's commercial structure, network and client portfolio.

· It advances the Company's stated strategy of targeting the smart textiles market.

 

Terms of the Acquisition

 

Directa Plus S.p.A has acquired a 60% interest in Osmotek for €60,000. The proceeds will be used for ongoing working capital purposes. The existing shareholders of Osmotek have not sold any shares in the transaction and remain committed to the business.

 

Osmotek was incorporated in September 2015 and, based on unaudited management information, in the period from incorporation to 31 October 2016 revenues were approximately €150,000 and it has reached its target of operating profit breakeven.

 

Under the terms of the Acquisition, Directa Plus S.p.A. will be the sole supplier of graphene-based products to Novaresin which will then produce the graphene-enhanced membranes that will be commercialised through DTS. Novaresin will provide the graphene-enhanced membranes exclusively to DTS and is prohibited from selling them directly to third parties.

 

Directa Plus will be responsible for the DTS operations, which will be based at the Company's existing headquarters in Lomazzo, Italy.

 

Giulio Cesareo, Chief Executive Officer of Directa Plus, said: "The establishment of Directa Textile Solutions represents a key milestone of our downstream integration strategy, and another step in the execution of our business plan. By moving up the value chain, we will be able to generate revenues from the provision of our G+ and also from the sale of the graphene-enhanced membrane to the end customer. Equally, we will be better able to communicate directly with major brands and so provide a product that meets their exact needs as well as pursuing our ingredient branding strategy.

 

"The market for smart textiles is vast. By partnering with a leading producer of textile membranes, Novaresin, with whom we have been working closely over the last year to develop graphene-enhanced textile membranes that are already being tested by a range of potential customers, we are strengthening our ability to target this key segment with our innovative, tailor-made solutions that have been independently certified as safe for human health and the environment. As a result, we are very excited about the prospects for Directa Plus Textile Solutions, which further increases our competitive position in the industry."

 

This announcement contains inside information as defined in Article 7 of the Market Abuse Regulation No. 596/2014 and is disclosed in accordance with the Company's obligations under Article 17 of those Regulations

 

Enquiries

 

Directa Plus plc

 

Giulio Cesareo, CEO

Marco Ferrari, CFO

+39 02 36714458

 

 

Cantor Fitzgerald Europe (Nominated Adviser and Broker)

 

Marc Milmo, David Foreman, Michael Reynolds (Corporate Finance)

Mark Westcott, David Banks (Sales)

+44 20 7894 7000

 

 

Luther Pendragon (Financial PR)

 

Harry Chathli, Claire Norbury, Alexis Gore

+44 20 7618 9100

 

About Directa Plus

 

Directa Plus is one of the largest producers and suppliers of graphene-based products for use in consumer and industrial markets worldwide. By incorporating Directa Plus' unique graphene blends, identified by the G+ brand, its customers can enhance the performance of their end products without significantly increasing their cost. Directa Plus graphene-based products are natural, chemical-free, sustainably produced and tailored to specific customer requirements for commercial applications such as smart textiles, tyres, composite materials and environmental solutions.

 

Established in 2005, the Company has a patented technology process and a scalable and exportable manufacturing model. It produces graphene-based products at its own factory in Lomazzo, Italy, and can set up additional production at customer locations to reduce transport costs, waste and time-to-utilisation. Directa Plus partners with customers to enable them to offer the high-performance benefits of graphene in their own products.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLFFIILVLVLIR
Date   Source Headline
15th Apr 20243:01 pmRNSNotification of major holdings
12th Apr 20247:00 amRNSGiPave® installed at Imola Circuit
25th Mar 20247:00 amRNSEUR 1,000,000 Loan Agreement Signed
22nd Mar 20247:00 amRNSCollaboration with UK-based Heathcoat Fabrics
26th Feb 20247:00 amRNSAcquisition of 49% minority interest in Setcar
31st Jan 20247:00 amRNSContract win with FORD Otosan
20th Dec 20237:00 amRNSAcquisition of groundbreaking technology
15th Dec 202311:44 amRNSExpansion of collaboration with Miguel Caballero
10th Nov 20237:00 amRNSChange of Nominated Adviser
27th Sep 20237:00 amRNSHalf-year Report
18th Sep 20237:00 amRNSStrategic collaboration with The SPECTRUM Group
8th Sep 20237:00 amRNSNotice of Interim Results
7th Sep 20237:00 amRNSSignificant contract secured with LIBERTY Galati
19th Jul 20237:00 amRNSProject tender awarded
29th Jun 20237:00 amRNSDirecta Plus receives two new Italian patents
22nd Jun 20237:00 amRNSNew concept for produced water decontamination
15th Jun 20235:40 pmRNSResult of AGM
8th Jun 20237:00 amRNSNew product launch
19th May 20237:00 amRNSPosting of Annual Report and Notice of AGM
10th May 20237:00 amRNSFinal Results
9th May 20237:00 amRNSNew contract with customer Alfredo Grassi
27th Apr 20237:00 amRNSNotice of Results Presentations
20th Mar 20237:00 amRNSNew Patent Granted
27th Feb 20237:00 amRNSTrading Update and Notice of Results
21st Dec 20227:00 amRNSNew significant contract with Pigmentsolution
5th Dec 20222:05 pmRNSSecond Price Monitoring Extn
5th Dec 20222:00 pmRNSPrice Monitoring Extension
2nd Dec 20227:00 amRNSTrading Update
29th Nov 20227:00 amRNSGrant Award
21st Nov 20227:00 amRNSDirectorate Change
28th Oct 20227:00 amRNSFirst Commercial Contract in Latin America
21st Oct 20227:00 amRNSFirst Major Commercial Contract for Gipave
17th Oct 20227:00 amRNSBoar Changes
17th Oct 20227:00 amRNSBoard Changes
29th Sep 202211:05 amRNSSecond Price Monitoring Extn
29th Sep 202211:00 amRNSPrice Monitoring Extension
29th Sep 20227:00 amRNSHalf-year Report
1st Sep 20227:00 amRNSTrading Statement
30th Aug 20227:00 amRNSUS Patent Notice
4th Aug 20227:00 amRNSPartnership Extension and US Patent Award
19th Jul 20227:00 amRNSAgreement with REDA Energy for Grafysorber
5th Jul 20227:00 amRNSSupply Agreement
22nd Jun 20227:00 amRNSGrant of Italian Filtration Patent
17th Jun 20223:40 pmRNSResult of AGM
17th Jun 20227:00 amRNSAGM Statement
19th May 20227:00 amRNSPosting of Annual Report and Notice of AGM
5th May 20227:00 amRNSFinal Results
22nd Apr 20227:00 amRNSPartnership to Develop Automotive Fabrics
4th Apr 20227:00 amRNSUS EPA Authorises Grafysorber for Use in US
7th Mar 20227:00 amRNSOxfordshire Starts Second Trial of GiPave

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.